BIOCRYST PHARMACEUTICALS INC
BCRX · NASDAQ
更新於 2026-10-15 07:53:16
- 今日最高
- $8.18
- 今日最低
- $7.97
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $8.02
- 昨天收盤價
- $8.05
- 成交量
- 5.63M
- 市值
- $2.05B
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-1.50
昨天價格區間
52週價格區間
公司概況
- 板塊
- HEALTHCARE
- 行業
- Biotechnology
- 子行業
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- 總部
- 4505 EMPEROR BOULEVARD, DURHAM, NC, UNITED STATES, 27703
- 國家
- US
- 上市日期
- 1994-03-04
- 財年截止
- December
- 流通股數
- 254.16M
- CIK
- 0000882796
- 官方網址
- www.biocryst.com
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
財務指標
營業收入
2026-06-30
$218.25M
2026-03-31
$156.41M
2025-12-31
$406.55M
2025-09-30
$159.39M
營業支出
2026-06-30
$115.94M
2026-03-31
$154.87M
2025-12-31
$136.64M
2025-09-30
$127.28M
淨利潤
2026-06-30
$78.39M
2026-03-31
-$721.81M
2025-12-31
$245.84M
2025-09-30
$12.89M
淨利潤率
2026-06-30
35.91%
2026-03-31
-461.47%
2025-12-31
60.47%
2025-09-30
8.09%
每股收益
2026-06-30
$0.30
2026-03-31
$0.14
2025-12-31
$1.12
2025-09-30
$0.16
息稅折舊攤銷前利潤
2026-06-30
$98.69M
2026-03-31
-$699.96M
2025-12-31
$266.19M
2025-09-30
$32.12M
有效稅率
2026-06-30
1.35%
2026-03-31
-0.13%
2025-12-31
0.87%
2025-09-30
-6.33%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $218.25M | $156.41M | $406.55M | $159.39M |
| 營業支出 | $115.94M | $154.87M | $136.64M | $127.28M |
| 淨利潤 | $78.39M | -$721.81M | $245.84M | $12.89M |
| 淨利潤率 | 35.91% | -461.47% | 60.47% | 8.09% |
| 每股收益 | $0.30 | $0.14 | $1.12 | $0.16 |
| 息稅折舊攤銷前利潤 | $98.69M | -$699.96M | $266.19M | $32.12M |
| 有效稅率 | 1.35% | -0.13% | 0.87% | -6.33% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。